Citing significant violations, FDA slams Ohio drug repackager with warning letter

Ohio-based drug repackager Safecor Health has been hit with a warning letter from the FDA that cites four "significant violations," including problems that could lead to drug mix-ups.   The warning letter, posted on the agency’s website, outlines four observations in the wake of a March inspection of the company’s facility in Woburn, Massachusetts.   The violations included the company’s inadequate inspection process of the packaging and labeling facilities that could lead to product mix-ups. For example, an FDA inspector found different capsules and tablets around a blister packaging machine during the packaging of chewable aspirin tablets, although records indicated that a line clearance had been performed.   “Your firm has a history of complaints for product mix-ups and has conducted internal recalls upon customer complaints,” the FDA said in the letter.   The inspection also found the company failed to establish and follow adequate written procedures for cleaning and maintaining equipment and that it failed to test samples of each drug component “for conformity with all appropriate written specifications for purity, strength, and quality.”   Additionally, inspectors cited Safecor’s quality control unit for not adhering to drug manufacturing standards.   “Our investigators observed partially completed and torn-up manufacturing records for a lot of children’s acetaminophen and stacks of loose printed forms on a desk next to the repackaging area,” the agency said.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!